The cost-effectiveness of prenatal detection for congenital heart disease using telemedicine screening

Journal of Telemedicine and Telecare

Volumn 19, Issue 4, 2013, Pages 190-196

  Mistry, Hema ^a   Gardiner, Helena M ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONGENITAL HEART MALFORMATION; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HUMAN; METHODOLOGY; PREGNANCY; PRENATAL DIAGNOSIS; REPRODUCIBILITY; TELEMEDICINE; UNITED KINGDOM;

COST-BENEFIT ANALYSIS; FEMALE; GREAT BRITAIN; HEART DEFECTS, CONGENITAL; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; REPRODUCIBILITY OF RESULTS; TELEMEDICINE;

EID: 84890160633     PISSN: 1357633X     EISSN: 17581109     Source Type: Journal    
DOI: 10.1258/jtt.2012.120418     Document Type: Article

References (34)

1. Kirwan D, et al. NHS Fetal Anomaly Screening Programme 18 {thorn} 0 to 20 {thorn} 6 Weeks Fetal Anomaly Scan National Standards and Guidance for England. Exeter: Royal College of Obstetricians and Gynaecologists, 2010.
2. Bull C. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. British Paediatric Cardiac Association. Lancet 1999;354:1242-7.
3. Central Cardiac Audit Database. Antenatal diagnosis. See http://www.ccad.org.uk/002/congenital.nsf/vwContent/Antenatal%20Diagnosis?Opendocument (last checked 15 July 2012)
4. Brown KL, Ridout DA, Hoskote A, Verhulst L, Ricci M, Bull C. Delayed diagnosis of congenital heart disease worsens preoperative condition and outcome of surgery in neonates. Heart 2006;92:1298-302.
5. Carvalho JS, Mavrides E, Shinebourne EA, Campbell S, Thilaganathan B. Improving the effectiveness of routine prenatal screening for major congenital heart defects. Heart 2002;88:387-91.
6. Tiny Tickers. Frequently asked questions: congenital heart disease/defects. See http://www.tinytickers.org/content/faq-chd (last checked 10 September 2012)
7. Begg L, Chan FY, Edie G, Hockey R, Wootton R. Minimum acceptable standards for digital compression of a fetal ultrasound video-clip. J Telemed Telecare 2001;7(Suppl. 2):88-90.
8. Fisk NM, Sepulveda W, Drysdale K, et al. Fetal telemedicine: six month pilot of real-time ultrasound and video consultation between the Isle of Wight and London. Br J Obstet Gynaecol 1996;103:1092-5.
9. Chan FY, Soong B, Watson D, Whitehall J. Realtime fetal ultrasound by telemedicine in Queensland. A successful venture? J Telemed Telecare 2001;7(Suppl. 2):7-11.
10. Sharma S, Parness IA, Kamenir SA, et al. Screening fetal echocardiography by telemedicine: efficacy and community acceptance. J Am Soc Echocardiogr 2003;16:202-8.
11. Dowie R, Mistry H, Young TA, Franklin RC, Gardiner HM. Cost implications of introducing a telecardiology service to support fetal ultrasound screening. J Telemed Telecare 2008;14:421-6.
12. Knowles R, Griebsch I, Dezateux C, Brown J, Bull C, Wren C. Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis. Health Technol Assess 2005;9:1-152, iii-iv
13. Jacklin PB, Roberts JA, Wallace P, et al. Virtual outreach: economic evaluation of joint teleconsultations for patients referred by their general practitioner for a specialist opinion. BMJ 2003;327:84.
14. HM Treasury. The Green Book: Appraisal and Evaluation in Central Government. See http://www.hm-treasury.gov.uk/d/green_book_complete.pdf (last checked 15 July 2012)
15. Mistry H. Economic Issues Associated with the Operation and Evaluation of Telemedicine. PhD Thesis. Brunel University, 2011.
16. Grant B, Morgan GJ, McCrossan BA, et al. Remote diagnosis of congenital heart disease: the impact of telemedicine. Arch Dis Child 2010;95:276-80.
17. Henderson JB. An economic appraisal of the benefits of screening for open spina bifida. Soc Sci Med 1982;16:545-60.
18. Gill M, Murday V, Slack J. An economic appraisal of screening for Down's syndrome in pregnancy using maternal age and serum alpha fetoprotein concentration. Soc Sci Med 1987;24:725-31.
19. Office of National Statistics. Interim Life Tables, England and Wales, 1980- 82 to 2005-07. London: Office for National Statistics, 2008.
20. Mangham LJ, Petrou S, Doyle LW, Draper ES, Marlow N. The cost of preterm birth throughout childhood in England and Wales. Pediatrics 2009;123:e312-27.
21. Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation. Oxford: Oxford University Press, 2006.
22. Stümpflen I, Stümpflen A, Wimmer M, Bernaschek G. Effect of detailed fetal echocardiography as part of routine prenatal ultrasonographic screening on detection of congenital heart disease. Lancet 1996;348:854-7.
23. Odibo AO, Coassolo KM, Stamilio DM, Ural SH, Macones GA. Should all pregnant diabetic women undergo a fetal echocardiography? A cost-effectiveness analysis comparing four screening strategies. Prenat Diagn 2006;26:39-44.
24. Buskens E, Steyerberg EW, Hess J, Wladimiroff JW, Grobbee DE. Routine prenatal screening for congenital heart disease: what can be expected? A decision-analytic approach. Am J Public Health 1997;87:962-7.
25. Garson A Jr, Allen HD, Gersony WM, et al. The cost of congenital heart disease in children and adults. A model for multicenter assessment of price and practice variation. Arch Pediatr Adolesc Med 1994;148:1039-45.
26. Moons P, Siebens K, De Geest S, Abraham I, Budts W, Gewillig M. A pilot study of expenditures on, and utilization of resources in, health care in adults with congenital heart disease. Cardiol Young 2001;11:301-13.
27. Dowie R, Mistry H, Young TA, et al. Telemedicine in pediatric and perinatal cardiology: economic evaluation of a service in English hospitals. Int J Technol Assess Health Care 2007;23:116-25.
28. Dowie R, Mistry H, Rigby M, Young TA, Weatherburn G, Rowlinson G, Franklin RC. A paediatric telecardiology service for district hospitals in south-east England: an observational study. Arch Dis Child 2009;94:273-7.
29. Buxton MJ, Dubois DJ, Turner RR, Sculpher MJ, Robinson PA, Searcy C. Cost implications of alternative treatments for AIDS patients with cryptococcal meningitis. Comparison of fluconazole and amphotericin B-based therapies. J Infect 1991;23:17-31.
30. Caviness AC, Cantor SB, Allen CH, Ward MA. A cost-effectiveness analysis of bacterial endocarditis prophylaxis for febrile children who have cardiac lesions and undergo urinary catheterization in the emergency department. Pediatrics 2004;113:1291-6.
31. Brown KL, Wray J, Wood TL, Mc Mahon AM, Burch M, Cairns J. Cost utility evaluation of extracorporeal membrane oxygenation as a bridge to transplant for children with end-stage heart failure due to dilated cardiomyopathy. J Heart Lung Transplant 2009;28:32-8.
32. Kirsch J, McGuire A. Establishing health state valuations for disease specific states: an example from heart disease. Health Econ 2000;9:149-58.
33. Brazier J, Roberts J, Tsuchiya A, Busschbach J. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 2004;13:873-84.
34. Grieve R, Grishchenko M, Cairns J. SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility. Eur J Health Econ 2009;10:15-23